Prophylaxis of neonatal respiratory distress syndrome by intra-amniotic administration of pulmonary surfactant

Chinese Medical Journal

Volumn 117, Issue 1, 2004, Pages 120-124

  Zhang, Jian Ping ^a   Wang, Ying Lan ^a   Wang, Yun Hui ^a   Zhang, Rui ^a   Chen, Huan ^a   Su, Hao Bin ^a  

^a SUN YAT SEN MEMORIAL HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Intra amniotic administration; Neonatal respiratory distress syndrome; Pulmonary surfactant

Indexed keywords

DIPALMITOYLPHOSPHATIDYLCHOLINE; LUNG SURFACTANT; PORACTANT;

ADULT; AMNION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DELIVERY; DOSE RESPONSE; DRUG ADMINISTRATION ROUTE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FETUS LUNG MATURITY; HOSPITALIZATION; HUMAN; INTRAAMNIOTIC DRUG ADMINISTRATION; LABORATORY TEST; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; NEWBORN HYPOXIA; NEWBORN MORTALITY; PREGNANCY; PREMATURE LABOR; PROPHYLAXIS; SIDE EFFECT; STATISTICAL SIGNIFICANCE;

AMNION; FEMALE; HUMANS; INFANT, NEWBORN; PULMONARY SURFACTANTS; RESPIRATORY DISTRESS SYNDROME, NEWBORN; SAFETY; TREATMENT OUTCOME;

EID: 1242284459     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. 51Cr-labeled red cells. Obstet Cynecol 1974;43:878-883.
2. Galan HL, Tennant LB, Marsh DR, et al. Paralysis of the preterm rabit fetus inhibits the pulmonary uptake of intraamniotic iron dextran. Am J Obstet Gynecol 1997;177: 42-49.
3. Galan HL, Kuehl TJ. Effect of intra-amniotic administration of Exosurf in preterm rabbit fetuses. Obstet Gynecol 1992; 80:604-608.
4. Hallman M, Lappalainen U, Bry K. Clearance of intra-amniotic lung surfactant: uptake and utilization by the fetal rabbit lung. Am J Physiol 1997;273:L55-L63.
5. Rodrigues CJ, Tannuri U, Tannuri AC, et al. Prenatal tracheal ligation or intra-amniotic administration of surfactant or dexamethasone prevents some structural changes in the pulmonary arteries of surgically created diaphragmatic hernia in rabbits. Rev Hosp Clin Fac Med Sao Paulo 2002;57:1-8.
6. Petrikovsky BM, Lysikiewicz A, Markin CB. In utero surfactant administration to preterm humanfetuses using endoscopy. Fetal Diagn Ther 1995;10:127-130.
7. Cosmi EV, La Torre R, Piazze JJ, et al. Intraamniotic surfactant for prevention of neonatal respiratory distress syndrome (NRDS) : rationale and personal experience. Eur J Obstet Gynecol Reprod Biol 1997;71:135-139.
8. Zhang JP, Wang YL, Liu YL, et al. Prevent neonatal respiratory distress syndrome by intra-amniotic administration of pulmonary surfactant: a case report. Chin J Obstet Gynecol (Chin) 2002;37:256.
9. Iwamori M, Hirota K, Utsuki T, et al. Sensitive method for the determination of pulmonary surfactantphospholipid/sphingomyelin ratio in human amniotic fluids for the diagnosis ofrespiratory distress syndrome by thin-layer chromatography-immunostaining. Anal Biochem 1996;238:29-33.
10. Ragosch V, Hundertmark S, Stolowsky C, et al. Prenatal determination of lung maturity from amniotic fluid-indications and new methods. Geburtshilfe Frauenheilkd 1994; 54: 679-684.
11. Galan HL, Cipriani C, Coalson JJ, et al. Surfactant replacement therapy in utero for prevention of hyaline membrane disease in the preterm baboon. Am J Obstet Gynecol 1993;169:817-824.
12. Field NT, Gilbert WM. Current status of amniotic fluid tests of fetal maturity. Clin Obstet Gynecol 1997;40:366-386.